EP Wealth Advisors LLC Buys 3,593 Shares of Danaher Co. (NYSE:DHR)

EP Wealth Advisors LLC increased its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 15.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,065 shares of the conglomerate's stock after buying an additional 3,593 shares during the quarter. EP Wealth Advisors LLC's holdings in Danaher were worth $7,525,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FMR LLC grew its stake in shares of Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock valued at $6,566,116,000 after purchasing an additional 3,217,631 shares during the period. TD Asset Management Inc raised its stake in Danaher by 99.0% during the second quarter. TD Asset Management Inc now owns 1,358,706 shares of the conglomerate's stock worth $339,473,000 after acquiring an additional 675,952 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Danaher by 22.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate's stock valued at $761,475,000 after acquiring an additional 563,546 shares during the period. International Assets Investment Management LLC boosted its stake in shares of Danaher by 40,196.5% in the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock valued at $119,539,000 after purchasing an additional 428,897 shares in the last quarter. Finally, Montrusco Bolton Investments Inc. grew its holdings in shares of Danaher by 30.4% in the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate's stock worth $465,617,000 after purchasing an additional 397,671 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Performance

DHR traded up $2.25 on Friday, hitting $230.12. The company's stock had a trading volume of 3,098,922 shares, compared to its average volume of 2,879,009. Danaher Co. has a 12 month low of $215.68 and a 12 month high of $281.70. The company's 50 day simple moving average is $250.76 and its 200-day simple moving average is $258.32. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The firm has a market cap of $166.21 billion, a P/E ratio of 43.92, a price-to-earnings-growth ratio of 4.35 and a beta of 0.83.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same period last year, the company earned $2.02 EPS. Danaher's revenue for the quarter was up 3.1% compared to the same quarter last year. Analysts forecast that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.47%. Danaher's payout ratio is currently 20.61%.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent analyst reports. KeyCorp boosted their price target on shares of Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a research report on Wednesday, October 23rd. Wells Fargo & Company started coverage on Danaher in a research report on Tuesday, August 27th. They set an "equal weight" rating and a $280.00 price target on the stock. UBS Group cut their price objective on Danaher from $309.00 to $305.00 and set a "buy" rating for the company in a research report on Wednesday, October 23rd. TD Cowen increased their target price on Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a report on Wednesday, October 23rd. Finally, Stephens restated an "overweight" rating and issued a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.